Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Scott Technology (SCT) / HY25

Revenue fell 13.6% and PBT 18% but tax rate halved kept NPAT flat

Operating earnings dropped below their historical range while an unusually low tax charge and a smaller working-capital build lifted reported cash.

Industrials / Automation and robotics

SCT revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $128.2m, versus $275.3m in FY25.

SCT EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • FY21 SCT: Unprecedented low ebitda margin. 10.2%; 4-period range 10.8% to 11.5%. EBITDA margin: 10.2%, unprecedented low; 4-period mean 11.1%, range 10.8%-11.5%.
  • HY24 SCT: Unprecedented high ebitda margin. 11.8%; 4-period range 10% to 11.5%. EBITDA margin: 11.8%, unprecedented high; 4-period mean 10.5%, range 10.0%-11.5%.
  • HY25 SCT: Outside range low ebitda margin. 10%; 4-period range 10.2% to 11.8%. EBITDA margin: 10.0%, below normal range; 4-period mean 10.9%, range 10.2%-11.8%.
  • FY25 SCT: Outside range high ebitda margin. 11.5%; 4-period range 10.2% to 11.3%. EBITDA margin: 11.5%, above normal range; 4-period mean 10.8%, range 10.2%-11.3%.
EBITDA margin: 11.5%, above normal range; 4-period mean 10.8%, range 10.2%-11.3%.

SCT operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $6.1m, versus $22.3m in FY25.

SCT working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • FY21 SCT: Outside range low operating working-capital movement. $6.3m; 4-period range $7.2m to $18.1m. Operating working-capital movement: NZ$6.3m, below normal range; 4/4 prior periods had builds averaging NZ$10.9m, and none had a working-capital release.
  • HY23 SCT: Unprecedented low operating working-capital movement. $-4.9m; 4-period range $4.6m to $25.9m. Operating working-capital movement: NZ$-4.9m, unprecedented low; 4/4 prior periods had builds averaging NZ$14.6m, and none had a working-capital release.
  • HY24 SCT: Unprecedented high operating working-capital movement. $25.9m; 4-period range $-4.9m to $14.9m. Operating working-capital movement: NZ$25.9m, unprecedented high; 3/4 prior periods had builds averaging NZ$10.8m, and 1 had releases averaging NZ$-4.9m.
  • FY25 SCT: Unprecedented high operating working-capital movement. $18.1m; 4-period range $6.3m to $10.7m. Operating working-capital movement: NZ$18.1m, unprecedented high; 4/4 prior periods had builds averaging NZ$8.0m, and none had a working-capital release.
Operating working-capital movement: NZ$18.1m, unprecedented high; 4/4 prior periods had builds averaging NZ$8.0m, and none had a working-capital release.
Release date
16 April 2025
Published
21 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY25 vs HY24

Revenue

$121.7m

-13.6% ↓ vs $140.9m

EBITDA

$12.2m

-26.6% ↓ vs $16.6m

Net profit after tax

$4.4m

flat vs $4.4m

Net cash inflow from operating activities

$14.5m

+288.2% ↑ vs −$7.7m

Interim dividend per share

3.0c

-40.0% ↓ vs 5.0c

Profit before tax

$5m

-18.0% ↓ vs $6.1m

Total assets

$244.4m

-4.5% ↓ vs $255.8m

What changed

Revenue fell 13.6% to NZ$121.7m, an unprecedented low against Annolyse's historical baseline (4-period mean +9.2%, range +5.3% to +13.3%)

EBITDA fell 26.6% to NZ$12.2m and the EBITDA margin compressed to 10.0%, below the historical normal range (mean 10.9%, range 10.2% to 11.8%). PBT fell 18.0% to NZ$5.0m, but NPAT was effectively flat at NZ$4.4m (0.0%) because the effective tax rate dropped to 12.9% from 26.4% — an unprecedented low versus the historical mean of 26.3%.

Operating cash flow swung from –NZ$7.7m to +NZ$14.5m, capex fell to NZ$1.9m from NZ$5.1m, and gross borrowings reduced 25.4% to NZ$25.5m. The interim dividend was cut 40% to 3.0 cps; net debt / EBITDA sits at 1.1x, within the historical range.

What matters

Tax distortion is doing the work in the headline

Management's "stable net profit" framing relies on an effective tax rate that is unprecedentedly low against the supplied historical baseline. PBT is the cleaner operating read and it is down 18.0%, with the gap between PBT growth (–18.0%) and NPAT growth (0.0%) entirely a tax-rate effect. Until the rate driver is explained, NPAT durability cannot be assumed.

Operating performance broke below the supplied historical range, not just versus HY24. Revenue growth of –13.6% sits outside the prior 5.3–13.3% range, EBITDA margin of 10.0% sits below the 10.2–11.8% range, and ROE of 3.6% is below the 3.9–7.4% range. This is an industry-cycle drawdown (management cites the lag from slow FY24 order intake), not a one-period miss.

Cash improved sharply but the quality is mixed. Cash conversion of 119.3% is at the upper edge of the historical range, helped by a working-capital build of NZ$4.6m that was smaller than the historical mean of NZ$8.3m. However, debtor days rose to 60.2 (upper edge) and inventory days to 55.4 (upper edge), so collection and inventory turn did not improve — the smaller absolute build largely reflects a lower revenue base and an unusually weak prior-period comparable.

Expectations

Forward work is flat at NZ$165m versus the prior period, which management says now carries a higher blended margin and recent large project wins lean to 2H25

Annualising current revenue gives NZ$243.5m, around 12% below FY24's NZ$276.1m, so a meaningful 2H step-up is required to keep the FY trajectory intact. The supplied prior shape shows HY24 was 51% of FY24 revenue and 63% of FY24 EBITDA, suggesting H1 has historically been the stronger half — a normal seasonal pattern alone will not close the FY gap.

The Destination 2030 NZ$530m revenue target implies a 16.8% revenue CAGR from current run-rate. The release does not provide segment-level forward work or order intake to support that path.

Quality of result

The NPAT line is the lowest-quality element of the result

PBT fell 18.0% and EBITDA margin compressed below its historical range; the 12.9% tax rate, unexplained in the supplied excerpts, is what kept reported NPAT flat. Operating cash improvement is partly real (capex stepped down to 1.5% of revenue from 6.4%) and partly an optics effect against a –NZ$7.7m prior comparable that management itself describes as containing "large anomalies."

The working-capital position is the key tension. The aggregate movement was favourable versus history, but the underlying days metrics moved the wrong way: receivables took 13.8 days longer and inventory 8.5 days longer to turn. In a project-based industrial business, that combination — smaller dollar build but extended days against a falling revenue base — typically signals delayed milestone billings and slower customer sign-off rather than improved working-capital discipline. The dividend cut from 5.0 cps to 3.0 cps and the move to a 55.6% NPAT payout (versus 90.9%) is consistent with management preserving cash against this backdrop.

Unresolved

Open questions

Why did the effective tax rate drop to 12.9% from 26.4%, and is the driver one-off or expected to persist?
What is causing debtor days to extend to 60.2 and inventory days to 55.4 against a falling revenue base, and how much of contract assets (NZ$28.0m) is dependent on customer sign-off in 2H25?
How much of the NZ$165m forward work converts to revenue in 2H25 versus FY26, and at what blended margin?
Was the dividend cut to 3.0 cps a signal about expected 2H25 cash generation or a structural reset of the payout policy?
What FY30 revenue path and segment mix underpin the 16.8% CAGR implied by the Destination 2030 target?

This briefing cannot assess order intake trends, customer concentration, or the contracted versus pipeline split of the NZ$165m forward work from the supplied excerpts.

Chat

Ask about SCT HY25

Ask follow-up questions about Scott Technology's HY25 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SCT HY25

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Scott Technology's HY25 result.

Why did the effective tax rate drop to 12.9% from 26.4%, and is the driver one-off or expected to persist?Why does "Tax distortion is doing the work in the headline" matter?How strong was the cash and earnings quality in HY25?What should I watch next for SCT after HY25?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

2025 Half Year Financial Statements

HY25 / financial report↗

2025 Half Year Investor Presentation

HY25 / results presentation↗

2025 Half Year Results Announcement

HY25 / results release↗

company filing

HY25 / results announcement↗

Prior comparable period

2024 Half Year Financial Statements

HY24 / financial report↗

2024 Half Year Results Announcement

HY24 / results release↗

company filing

HY24 / results announcement↗

Full-year context

NZX Results Announcement

FY24 / results announcement↗

NZX Results Announcement

FY24 / results release↗

Scott Annual Report 2024

FY24 / financial report↗

Release context

Annual Meeting Results 2024

HY25 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 18.0pp, with a distortion flag in the result.

→

Cash conversion quality

This result converted 119.3% of EBITDA to operating cash flow, +165.8pp versus the prior comparable period.

→

Dividend coverage and payout pressure

Dividend payout versus NPAT is 55.6%.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 1.10x, -0.10x versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SCT publishes next

Get the next Scott Technology briefing and related NZX reporting-season updates by email.